UNICHEM LABORATORIES
Back to Balance Sheet
|
UNICHEM LABORATORIES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹886 Cr | ₹992 Cr | ₹738 Cr | ₹640 Cr | ₹552 Cr |
What is the latest Total Current Liabilities ratio of UNICHEM LABORATORIES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹886 Cr |
| Mar2025 | ₹992 Cr |
| Mar2024 | ₹738 Cr |
| Mar2023 | ₹640 Cr |
| Mar2022 | ₹552 Cr |
How is Total Current Liabilities of UNICHEM LABORATORIES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹886 Cr | -10.69 | |
| Mar2025 | ₹992 Cr | 34.49 | |
| Mar2024 | ₹738 Cr | 15.32 | |
| Mar2023 | ₹640 Cr | 15.84 | |
| Mar2022 | ₹552 Cr | - | |
Compare Total Current Liabilities of peers of UNICHEM LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| UNICHEM LABORATORIES | ₹4,259.6 Cr | -5.4% | 35% | -1.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,870.0 Cr | 0.8% | 8.3% | 17.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹194,316.0 Cr | 7.1% | 9% | 4.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹169,316.0 Cr | 2% | 12.1% | 49.6% | Stock Analytics | |
| CIPLA | ₹115,477.0 Cr | -0.7% | 4.1% | -3.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,156.0 Cr | -1.7% | -4.2% | -3.1% | Stock Analytics | |
UNICHEM LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| UNICHEM LABORATORIES | -5.4% |
35% |
-1.6% |
| SENSEX | 0.6% |
1.2% |
-7.8% |
You may also like the below Video Courses